Compounding FDA Hospitals Omnicell 
Omnicell
JANUARY 10, 2023
Director, Central Pharmacy Product Marketing, Omnicell IV automation technology combined with robust expert services is a game-changer for reducing drug spend while enhancing patient safety. Sterile compounding is also one of the costliest functions in pharmacy operations. Insourcing IV compounding services at Moses H.
Omnicell
SEPTEMBER 5, 2022
Mark Neuenschwander Founding Director, THRIVCoalition.org Seminal research from 1997 on IV compounding discovered that 9 percent of manually compounded sterile preparations had incorrect ingredients and/or volumes. All this means hospitals must prepare the majority of their IVs in-house and, we believe this will continue.
Expert insights. Personalized for you.
52 
Let's personalize your content